| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Grant | Common Stock | 2.5k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 764 | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 259 | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 420 | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 800 | $0.00 | $0 | | 05/31/2023 |
| 07/15/2022 | ACELRX PHARMACEUTICALS INC | ACRX | Grant | | 15.5k | $0.00 | $0 | | 07/15/2022 |
| 07/15/2022 | ACELRX PHARMACEUTICALS INC | ACRX | Grant | Stock Option (Right to Buy) | 31k | $0.23 | $7.2k | | 07/15/2022 |
| 06/16/2022 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 40k | $0.36 | $14.4k | | 06/16/2022 |
| 06/17/2021 | ACELRX PHARMACEUTICALS INC | ACRX | Grant | | 10k | $0.00 | $0 | | 06/17/2021 |
| 06/17/2021 | ACELRX PHARMACEUTICALS INC | ACRX | Grant | Stock Option (Right to Buy) | 20k | $1.41 | $28.2k | | 06/17/2021 |
| 06/17/2021 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 20k | $0.00 | $0 | | 06/17/2021 |
| 06/16/2020 | ACELRX PHARMACEUTICALS INC | ACRX | Grant | Stock Option (Right to Buy) | 15k | $1.43 | $21.4k | | 06/16/2020 |
| 06/16/2020 | ACELRX PHARMACEUTICALS INC | ACRX | Grant | | 7.5k | $0.00 | $0 | | 06/16/2020 |
| 08/19/2019 | Kala Pharmaceuticals, Inc. | KALA | Exercise | Stock Option (right to buy) | 2.9k | $0.68 | $2k | | 08/19/2019 |
| 08/19/2019 | Kala Pharmaceuticals, Inc. | KALA | Exercise | Stock Option (right to buy) | 1.9k | $0.47 | $913.7 | | 08/19/2019 |
| 06/05/2019 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 21k | $5.35 | $112.4k | | 06/05/2019 |
| 05/30/2019 | Kala Pharmaceuticals, Inc. | KALA | Purchase | Common stock | 5k | $5.42 | $27.1k | | 05/30/2019 |
| 06/14/2018 | ACELRX PHARMACEUTICALS INC | ACRX | Grant | Stock Options (Right to Buy) | 15k | $4.13 | $61.9k | | 06/14/2018 |
| 06/12/2018 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 13k | $13.73 | $177.9k | | 06/12/2018 |
| 07/19/2017 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 13k | $15.00 | $194.4k | | 07/19/2017 |
| 06/15/2017 | ACELRX PHARMACEUTICALS INC | ACRX | Grant | | 15k | $2.30 | $34.5k | | 06/15/2017 |